The Australia and New Zealand Endotoxin Testing Market was valued at USD 23.24 million in 2025, and is expected to reach USD 57.59 million by 2035, growing at a CAGR of 9.5%. Primary demand for endotoxin testing comes from pharmaceutical and biotechnology companies.

Key Growth Drivers:

Increasing Regulatory Requirements:

Increasing regulatory requirements for endotoxin testing in pharmaceutical and biotechnology industries drive market growth. This leads to higher demand for endotoxin testing services.

Advances in Technology:

Advances in technology enable faster and more accurate endotoxin testing. This increases adoption of endotoxin testing in various industries.

Growing Demand for Medical Devices:

Growing demand for medical devices also fuels market growth. This leads to higher demand for endotoxin testing services.

Request a Free Sample Report With Table of Contents:

www.expertmarketresearch.com/reports/australia-and-new-zealand-endotoxin-testing-market/requestsample

Emerging Trends:

Emerging trends in the market include increasing adoption of automated endotoxin testing systems. These systems offer faster and more accurate results.

Regional Landscape:

The market dynamics vary across regions, with australia being the largest market. New zealand is also a significant market due to its growing pharmaceutical industry.

Competitive Landscape:

Major companies such as charles river laboratories and lonza group dominate the market. These companies offer a range of endotoxin testing services.

Outlook:

The future market outlook is positive, driven by increasing demand for endotoxin testing services. Expert Market Research expects the market to grow significantly till 2035, driven by regulatory requirements and advances in technology.